Assignee
CATABASIS PHARMACEUTICALS INC
US·14 granted patents·23 pending applications·34 citations·filing 2011–2020
Top patents by PatentIndex Score
37 records- 0190US8765964B2Fatty acid niacin conjugates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2013·Granted Jul 1, 2014·7 cites·23 claims
- 0288USRE45275EFatty acid niacin conjugates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2013·Granted Dec 2, 2014·5 cites·23 claims
- 0387US9278136B2Fatty acid niacin conjugates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2014·Granted Mar 8, 2016·4 cites·45 claims
- 0487US9238077B2Fatty acid niacin conjugates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2014·Granted Jan 19, 2016·4 cites·61 claims
- 0587USRE45261EFatty acid niacin conjugates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2013·Granted Nov 25, 2014·5 cites·18 claims
- 0677USRE46605EFatty acid niacin conjugates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2015·Granted Nov 14, 2017·1 cites·52 claims
- 0777US2021169905A1Fatty acid acetylated salicylates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0876US9486534B2Niacin conjugated fatty acid mixtures and their usesCATABASIS PHARMACEUTICALS INC·Filed 2015·Granted Nov 8, 2016·1 cites·9 claims
- 0976US9458094B2Fatty acid acetylated salicylates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2014·Granted Oct 4, 2016·1 cites·19 claims
- 1076US9272984B2Fatty acid acetylated salicylates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2014·Granted Mar 1, 2016·1 cites·16 claims
- 1173USRE46608EFatty acid niacin conjugates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2015·Granted Nov 14, 2017·1 cites·53 claims
- 1273US9289503B2Fatty acid fumarate derivatives and their usesCATABASIS PHARMACEUTICALS INC·Filed 2015·Granted Mar 22, 2016·1 cites·6 claims
- 1372US10251845B2Fatty acid cysteamine conjugates and their use as activators of autophagyCATABASIS PHARMACEUTICALS INC·Filed 2015·Granted Apr 9, 2019·1 cites·24 claims
- 1471US2020046738A1Fatty acid acetylated salicylates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1570US9708245B2Fatty acid acylated salicylates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 18, 2017·1 cites·18 claims
- 1668US2018325923A1Fatty acid acetylated salicylates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1767US9084826B2Fatty acid conjugates of statin and FXR agonists; compositions and method of usesCATABASIS PHARMACEUTICALS INC·Filed 2013·Granted Jul 21, 2015·1 cites·15 claims
- 1867US2018028674A1Fatty acid niacin conjugates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1964US2017246193A1Fatty acid acetylated salicylates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2064US2016346397A1Fatty acid niacin conjugates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2156US2014093513A1Methods of lowering proprotein conversate subtilisin/kexin type 9 (pcsk9)CATABASIS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2255US2016340294A1Fatty acid fumarate derivatives and their usesCATABASIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2354US2013244966A1Fatty acid antiviral conjugates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 2453US2020038342A1Fatty acid cysteamine conjugates and their use as activators of autophagyCATABASIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2551US2017144972A1Methods of lowering proprotein convertase subtilisin/kexin type 9 (pcsk9)CATABASIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2649US2016129122A1Fatty acid antiviral conjugates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2747US2016287712A1Fatty acid niacin conjugatesCATABASIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2844US2016106712A1Fatty acid cox inhibitor derivatives and their usesCATABASIS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2944US2021023029A1Edasalonexent dosing regimen for treating muscular dystrophyCATABASIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3043US2015352094A1Use of fatty acid niacin conjugates for treating diseasesCATABASIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3142US2017342046A1Fatty Acid Cysteine-Based Conjugates and Their Use in Treating Medical DisordersCATABASIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3242US2014288025A1Fatty acid antiviral conjugates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3339US2011212958A1Fatty acid raloxifene derivatives and their usesCATABASIS PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 3439US2013045939A1Fatty acid macrolide derivatives and their usesCATABASIS PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 3539US2011213028A1Fatty acid mycophenolate derivatives and their usesCATABASIS PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 3638US2017073305A1Fatty acid amides, compositions and methods of useCATABASIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3738US2016015819A1Fatty acid conjugates of statin and fxr agonists: compositions and methods of useCATABASIS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CATABASIS PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →